.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
he would caress her arm and repeatedly tell her, "babe, babe, it's ok."
.
.
.
.